Igor M. Belyakov

6.2k total citations
80 papers, 5.0k citations indexed

About

Igor M. Belyakov is a scholar working on Immunology, Virology and Epidemiology. According to data from OpenAlex, Igor M. Belyakov has authored 80 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Immunology, 39 papers in Virology and 22 papers in Epidemiology. Recurrent topics in Igor M. Belyakov's work include Immune Cell Function and Interaction (44 papers), Immunotherapy and Immune Responses (39 papers) and HIV Research and Treatment (35 papers). Igor M. Belyakov is often cited by papers focused on Immune Cell Function and Interaction (44 papers), Immunotherapy and Immune Responses (39 papers) and HIV Research and Treatment (35 papers). Igor M. Belyakov collaborates with scholars based in United States, Russia and France. Igor M. Belyakov's co-authors include Jay A. Berzofsky, Jeffrey D. Ahlers, Bernard Moss, Warren Strober, Patricia L. Earl, Masaki Terabe, Qing Zhu, Brian L. Kelsall, Amiran Dzutsev and Dennis M. Klinman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Igor M. Belyakov

78 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor M. Belyakov United States 41 3.4k 1.7k 1.4k 1.3k 732 80 5.0k
Jeffrey D. Ahlers United States 29 2.4k 0.7× 1.3k 0.8× 887 0.6× 904 0.7× 529 0.7× 44 3.4k
Melissa Pope United States 41 4.4k 1.3× 3.4k 2.0× 1.1k 0.8× 965 0.8× 1.1k 1.5× 80 6.4k
Michael A. Chattergoon United States 30 2.3k 0.7× 986 0.6× 899 0.6× 1.3k 1.0× 719 1.0× 58 3.8k
Herman F. Staats United States 39 3.2k 0.9× 961 0.6× 1.1k 0.8× 1.2k 1.0× 970 1.3× 109 5.5k
Michael S. Wyand United States 31 2.1k 0.6× 2.4k 1.4× 1.3k 0.9× 817 0.6× 969 1.3× 53 4.0k
C. David Pauza United States 42 3.3k 1.0× 2.9k 1.7× 1.2k 0.9× 972 0.8× 1.4k 1.9× 145 5.7k
Tong‐Ming Fu United States 36 2.5k 0.7× 901 0.5× 2.3k 1.6× 1.3k 1.0× 912 1.2× 100 5.1k
Gerard C.F. van Duijnhoven Netherlands 9 3.1k 0.9× 1.5k 0.9× 613 0.4× 1.2k 0.9× 687 0.9× 10 4.4k
Richard S. Kornbluth United States 30 2.2k 0.6× 1.5k 0.9× 728 0.5× 803 0.6× 786 1.1× 59 3.6k
Carla Oseroff United States 39 4.2k 1.2× 708 0.4× 1.7k 1.2× 2.4k 1.8× 615 0.8× 60 6.0k

Countries citing papers authored by Igor M. Belyakov

Since Specialization
Citations

This map shows the geographic impact of Igor M. Belyakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor M. Belyakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor M. Belyakov more than expected).

Fields of papers citing papers by Igor M. Belyakov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor M. Belyakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor M. Belyakov. The network helps show where Igor M. Belyakov may publish in the future.

Co-authorship network of co-authors of Igor M. Belyakov

This figure shows the co-authorship network connecting the top 25 collaborators of Igor M. Belyakov. A scholar is included among the top collaborators of Igor M. Belyakov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor M. Belyakov. Igor M. Belyakov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belyakov, Igor M., et al.. (2023). The use of electroporation to deliver DNA-based vaccines. Expert Review of Vaccines. 23(1). 102–123. 20 indexed citations
2.
Belyakov, Igor M., Ellen M. Zimmermann, Dmitry Isakov, et al.. (2012). Effect of targeted drug delivery with G5-MTX dendrimers on induced T regulatory (iTreg) CD4+ T cells in an inflammatory bowel disease (IBD) colitis model (52.1). The Journal of Immunology. 188(1_Supplement). 52.1–52.1. 3 indexed citations
3.
Zhu, Qing, Guofeng Zhang, Zijian Wang, et al.. (2012). Large intestine–targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nature Medicine. 18(8). 1291–1296. 139 indexed citations
4.
Sui, Yongjun, Qing Zhu, Susan J. Gagnon, et al.. (2010). Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proceedings of the National Academy of Sciences. 107(21). 9843–9848. 72 indexed citations
5.
Belyakov, Igor M. & Jeffrey D. Ahlers. (2009). What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?. The Journal of Immunology. 183(11). 6883–6892. 195 indexed citations
6.
Belyakov, Igor M. & Jeffrey D. Ahlers. (2009). Comment on “Trafficking of Antigen-Specific CD8+ T Lymphocytes to Mucosal Surfaces following Intramuscular Vaccination”. The Journal of Immunology. 182(4). 1779–1779. 12 indexed citations
7.
Ahlers, Jeffrey D. & Igor M. Belyakov. (2009). Strategies for optimizing targeting and delivery of mucosal HIV vaccines. European Journal of Immunology. 39(10). 2657–2669. 23 indexed citations
8.
Belyakov, Igor M., Jeffrey D. Ahlers, Gary J. Nabel, Bernard Moss, & Jay A. Berzofsky. (2008). Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization. Virology. 381(1). 106–115. 40 indexed citations
9.
Belyakov, Igor M. & Jeffrey D. Ahlers. (2008). Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine. Trends in Immunology. 29(11). 574–585. 29 indexed citations
10.
Belyakov, Igor M., Steven Kozlowski, Michael G. Mage, et al.. (2007). Role of  3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs. International Immunology. 19(12). 1413–1420. 6 indexed citations
13.
Belyakov, Igor M., Scott A. Hammond, Jeffrey D. Ahlers, Gregory M. Glenn, & Jay A. Berzofsky. (2004). Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. Journal of Clinical Investigation. 113(7). 998–1007. 7 indexed citations
14.
Belyakov, Igor M., et al.. (2004). Cytokines in the Thymus: Production and Biological Effects. Current Medicinal Chemistry. 11(4). 447–464. 80 indexed citations
15.
Belyakov, Igor M., Patricia L. Earl, Amiran Dzutsev, et al.. (2003). Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proceedings of the National Academy of Sciences. 100(16). 9458–9463. 237 indexed citations
16.
Bukreyev, Alexander & Igor M. Belyakov. (2002). Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?. Expert Review of Vaccines. 1(2). 233–245. 7 indexed citations
17.
Chung, Doo Hyun, Igor M. Belyakov, Michael A. Derby, et al.. (2001). Competitive Inhibition In Vivo and Skewing of the T Cell Repertoire of Antigen-Specific CTL Priming by an Anti-Peptide-MHC Monoclonal Antibody. The Journal of Immunology. 167(2). 699–707. 8 indexed citations
18.
Horner, Anthony A., Sandip K. Datta, Kenji Takabayashi, et al.. (2001). Immunostimulatory DNA-Based Vaccines Elicit Multifaceted Immune Responses Against HIV at Systemic and Mucosal Sites. The Journal of Immunology. 167(3). 1584–1591. 86 indexed citations
19.
Poláková, K, Daniel Plaksin, Doo Hyun Chung, et al.. (2000). Antibodies Directed Against the MHC-I Molecule H-2Dd Complexed with an Antigenic Peptide: Similarities to a T Cell Receptor with the Same Specificity. The Journal of Immunology. 165(10). 5703–5712. 27 indexed citations
20.
Ahlers, Jeffrey D., et al.. (1999). Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections. Immunological Reviews. 170(1). 151–172. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026